vs

Side-by-side financial comparison of Sprinklr, Inc. (CXM) and U S PHYSICAL THERAPY INC (USPH). Click either name above to swap in a different company.

Sprinklr, Inc. is the larger business by last-quarter revenue ($219.1M vs $202.7M, roughly 1.1× U S PHYSICAL THERAPY INC). U S PHYSICAL THERAPY INC runs the higher net margin — 2.0% vs 1.3%, a 0.7% gap on every dollar of revenue. On growth, U S PHYSICAL THERAPY INC posted the faster year-over-year revenue change (12.3% vs 9.2%). U S PHYSICAL THERAPY INC produced more free cash flow last quarter ($21.0M vs $19.8M). Over the past eight quarters, U S PHYSICAL THERAPY INC's revenue compounded faster (14.1% CAGR vs 6.2%).

Sprinklr is an American software company that develops a software as a service (SaaS) customer experience management (CXM) platform. The company's software, also called Sprinklr, combines different applications for social media marketing, social advertising, content management, collaboration, employee advocacy, customer care, social media research, and social media monitoring.

U.S. Physical Therapy Inc. operates hundreds of outpatient physical therapy clinics across the U.S. It offers rehabilitative care for patients recovering from injuries, surgeries, chronic pain and mobility impairments, plus specialized services including sports medicine and pediatric rehabilitation.

CXM vs USPH — Head-to-Head

Bigger by revenue
CXM
CXM
1.1× larger
CXM
$219.1M
$202.7M
USPH
Growing faster (revenue YoY)
USPH
USPH
+3.2% gap
USPH
12.3%
9.2%
CXM
Higher net margin
USPH
USPH
0.7% more per $
USPH
2.0%
1.3%
CXM
More free cash flow
USPH
USPH
$1.2M more FCF
USPH
$21.0M
$19.8M
CXM
Faster 2-yr revenue CAGR
USPH
USPH
Annualised
USPH
14.1%
6.2%
CXM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CXM
CXM
USPH
USPH
Revenue
$219.1M
$202.7M
Net Profit
$2.9M
$4.2M
Gross Margin
66.4%
19.8%
Operating Margin
5.3%
8.3%
Net Margin
1.3%
2.0%
Revenue YoY
9.2%
12.3%
Net Profit YoY
-72.2%
-55.1%
EPS (diluted)
$0.01
$-0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXM
CXM
USPH
USPH
Q4 25
$219.1M
$202.7M
Q3 25
$212.0M
$197.1M
Q2 25
$205.5M
$197.3M
Q1 25
$202.5M
$183.8M
Q4 24
$200.7M
$180.4M
Q3 24
$197.2M
$168.0M
Q2 24
$196.0M
$167.2M
Q1 24
$194.2M
$155.7M
Net Profit
CXM
CXM
USPH
USPH
Q4 25
$2.9M
$4.2M
Q3 25
$12.6M
$13.1M
Q2 25
$-1.6M
$12.4M
Q1 25
$98.7M
$9.9M
Q4 24
$10.5M
$9.2M
Q3 24
$1.8M
$6.6M
Q2 24
$10.6M
$7.5M
Q1 24
$21.1M
$8.0M
Gross Margin
CXM
CXM
USPH
USPH
Q4 25
66.4%
19.8%
Q3 25
68.2%
18.7%
Q2 25
69.5%
21.1%
Q1 25
71.0%
16.9%
Q4 24
71.2%
18.0%
Q3 24
72.6%
17.3%
Q2 24
73.9%
20.3%
Q1 24
75.5%
18.2%
Operating Margin
CXM
CXM
USPH
USPH
Q4 25
5.3%
8.3%
Q3 25
7.7%
12.8%
Q2 25
-0.9%
12.6%
Q1 25
5.2%
10.7%
Q4 24
3.9%
10.9%
Q3 24
-0.0%
7.6%
Q2 24
2.9%
9.3%
Q1 24
9.5%
9.6%
Net Margin
CXM
CXM
USPH
USPH
Q4 25
1.3%
2.0%
Q3 25
5.9%
6.7%
Q2 25
-0.8%
6.3%
Q1 25
48.7%
5.4%
Q4 24
5.2%
5.1%
Q3 24
0.9%
3.9%
Q2 24
5.4%
4.5%
Q1 24
10.9%
5.2%
EPS (diluted)
CXM
CXM
USPH
USPH
Q4 25
$0.01
$-0.44
Q3 25
$0.05
$0.48
Q2 25
$-0.01
$0.58
Q1 25
$0.35
$0.80
Q4 24
$0.04
$0.52
Q3 24
$0.01
$0.39
Q2 24
$0.04
$0.47
Q1 24
$0.07
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXM
CXM
USPH
USPH
Cash + ST InvestmentsLiquidity on hand
$189.6M
$35.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$558.1M
$476.4M
Total Assets
$1.1B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXM
CXM
USPH
USPH
Q4 25
$189.6M
$35.6M
Q3 25
$125.4M
$31.1M
Q2 25
$126.4M
$34.1M
Q1 25
$145.3M
$39.2M
Q4 24
$93.2M
$41.4M
Q3 24
$119.1M
$117.0M
Q2 24
$126.8M
$112.9M
Q1 24
$164.0M
$132.3M
Stockholders' Equity
CXM
CXM
USPH
USPH
Q4 25
$558.1M
$476.4M
Q3 25
$543.4M
$503.6M
Q2 25
$639.8M
$500.8M
Q1 25
$612.1M
$497.3M
Q4 24
$497.0M
$488.9M
Q3 24
$469.0M
$482.8M
Q2 24
$610.9M
$484.6M
Q1 24
$679.7M
$479.8M
Total Assets
CXM
CXM
USPH
USPH
Q4 25
$1.1B
$1.2B
Q3 25
$1.1B
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$1.2B
$1.2B
Q4 24
$970.3M
$1.2B
Q3 24
$983.8M
$1.0B
Q2 24
$1.1B
$1.0B
Q1 24
$1.2B
$1.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXM
CXM
USPH
USPH
Operating Cash FlowLast quarter
$20.0M
$24.9M
Free Cash FlowOCF − Capex
$19.8M
$21.0M
FCF MarginFCF / Revenue
9.0%
10.4%
Capex IntensityCapex / Revenue
0.1%
1.9%
Cash ConversionOCF / Net Profit
6.87×
6.00×
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$61.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXM
CXM
USPH
USPH
Q4 25
$20.0M
$24.9M
Q3 25
$34.8M
$19.9M
Q2 25
$83.8M
$34.9M
Q1 25
$5.4M
$-4.7M
Q4 24
$9.2M
$19.4M
Q3 24
$21.3M
$22.1M
Q2 24
$41.7M
$29.0M
Q1 24
$17.3M
$4.4M
Free Cash Flow
CXM
CXM
USPH
USPH
Q4 25
$19.8M
$21.0M
Q3 25
$34.4M
$15.6M
Q2 25
$83.5M
$31.6M
Q1 25
$4.6M
$-7.3M
Q4 24
$8.2M
$16.9M
Q3 24
$19.8M
$19.6M
Q2 24
$39.2M
$26.7M
Q1 24
$15.2M
$2.6M
FCF Margin
CXM
CXM
USPH
USPH
Q4 25
9.0%
10.4%
Q3 25
16.2%
7.9%
Q2 25
40.6%
16.0%
Q1 25
2.3%
-3.9%
Q4 24
4.1%
9.4%
Q3 24
10.1%
11.7%
Q2 24
20.0%
15.9%
Q1 24
7.9%
1.7%
Capex Intensity
CXM
CXM
USPH
USPH
Q4 25
0.1%
1.9%
Q3 25
0.2%
2.2%
Q2 25
0.1%
1.6%
Q1 25
0.4%
1.4%
Q4 24
0.5%
1.4%
Q3 24
0.8%
1.5%
Q2 24
1.3%
1.4%
Q1 24
1.1%
1.2%
Cash Conversion
CXM
CXM
USPH
USPH
Q4 25
6.87×
6.00×
Q3 25
2.76×
1.52×
Q2 25
2.81×
Q1 25
0.05×
-0.47×
Q4 24
0.88×
2.10×
Q3 24
11.58×
3.34×
Q2 24
3.92×
3.86×
Q1 24
0.82×
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXM
CXM

License And Service$190.3M87%
Professional Services$28.8M13%

USPH
USPH

Net Patient Revenues$169.7M84%
Industrial Injury Prevention Services Revenues$28.9M14%
Management Contract Revenues$2.3M1%

Related Comparisons